<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Regulation of Telepharmacy Practice</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Regulation of Telepharmacy Practice</h1>
    <p class="timestamp">Published: 2021-11-17 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Drug Enforcement Administration (DEA) is issuing this advanced notice of proposed rulemaking to obtain further information regarding the practice of telepharmacy. Telepharmacy is not specifically defined by the Controlled Substances Act (CSA) or DEA regulations; however, to the extent telepharmacies dispense controlled substances, they are under the purview of the CSA and DEA. DEA is considering promulgating regulations regarding telepharmacy and seeks to be fully informed about the practice...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Proposed Rule</p>
    <p><strong>Agency:</strong> Justice Department, Drug Enforcement Administration</p>
    <p><strong>Document Number:</strong> 2021-24948</p>
    <p><strong>Publication Date:</strong> 2021-11-17</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2021/11/17/2021-24948/regulation-of-telepharmacy-practice">https://www.federalregister.gov/documents/2021/11/17/2021-24948/regulation-of-telepharmacy-practice</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2021-24948</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
